Compound 73
Identifiers
- Canonical SMILES:
CCOC(=O)[C@H]1CCCN(C1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O
- IUPAC name:
ethyl 1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-3-carboxylate
- InChi:
InChI=1S/C32H38F3N3O4S/c1-2-42-31(41)22-8-5-16-38(20-22)26-9-3-4-10-28(26)43-27-13-12-21(18-25(27)32(33,34)35)23-19-24(23)30(40)36-14-7-17-37-15-6-11-29(37)39/h3-4,9-10,12-13,18,22-24H,2,5-8,11,14-17,19-20H2,1H3,(H,36,40)/t22-,23-,24+/m0/s1
- InChiKey:
IOORAGVPEMUXSU-KMDXXIMOSA-N
External links
44386427 |
23242419 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 7.00 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 617.25 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 4.83 | |||
TPSA | 78.95 | |||
RB | 13 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5449 | Periciazine | DB01608 | |
0.5030 | Butaperazine | DB13213 | |
0.4812 | Propiopromazine | DB11540 | |
0.4795 | Carphenazine | DB01038 | |
0.4706 | Daglutril | DB05796 | |
0.4694 | Mequitazine | DB01071 | |
0.4649 | Avacopan | DB15011 | |
0.4605 | Etymemazine | DB11517 | |
0.4578 | Metopimazine | DB13591 | |
0.4575 | Triflupromazine | DB00508 | |
0.4573 | Fluphenazine | DB00623 | |
0.4562 | Trifluoperazine | DB00831 | |
0.4529 | Acetophenazine | DB01063 | |
0.4528 | Acepromazine | DB01614 | |
0.4511 | Benazepril | DB00542 |